Roche cOmpleteTM, EDTA-free Protease Inhibitor Cocktail 3 package

The University of Virginia awarded contract A207_PO-0447341-V3 to Thomas Scientific on August 8, 2026. The contract encompasses the procurement of Roche cOmpleteTM, Ethylenediaminetetraacetic Acid (EDTA)-free Protease Inhibitor Cocktail in package units. The total contract value is $1,567.40, with 1,567 packages ordered at a unit price of $1.00 per package. Delivery is designated to the University of Virginia buyer.

The protease inhibitor cocktail specified under this contract award is a biochemical reagent commonly utilized in laboratory and research applications to prevent protein degradation during sample preparation and analysis. As a Virginia-based state institution, the University of Virginia's procurement through Thomas Scientific represents standard academic research supply acquisition. The contract documentation does not specify an explicit performance period beyond the award date of August 8, 2026, nor does it identify a particular county location or alternative place of performance beyond the contracting organization itself.